The development of mRNA vaccines is perhaps one of the greatest medical research success stories of the last decade. It has led to the use of very effective vaccines against covid-19 and has thus been instrumental in shortening the pandemic. RNA vaccines, unlike traditional vaccines, contain only the genetic information of the virus. The cells of the vaccinated individuals use this artificially produced genetic information to produce the specific antigen themselves and can thus naturally target the infectious disease in the event of subsequent contact with the virus. Join experts from a variety of disciplines to discuss the translational steps from basic science to large-scale clinical trials to regulatory approval. This Science Café is organized by the Center for Reproducible Science at the University of Zurich.

Panelists:

• PD Dr. Steve Pascolo, Department of Dermatology, University Hospital Zurich
• Prof. Stephen Senn, PhD, Statistical Consultant
• Prof. Leonhard Held, Professor for Biostatistics at UZH und Director of the CRS
• Dr. Cristina de Min, Drug Development Senior Expert

Moderation

• Anna-Katharina Ehlert, Board member at Reatch! Research. Think. Change. and Application Specialist Hematology at Roche Diagnostics.

Image: https://www.ema.europa.eu/en/news/ema-commissions-independent-research-prepare-real-world-monitoring-covid-19-vaccines